ALKERMES | 売上原価



Cost Of Sales 変化する 日付
AbbVie USD 4B 394M 2025-03
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
ALKERMES USD 49.2M 12.92M 2025-03
Amgen USD 2.6B 507M 2025-03
Biogen USD 629.3M 45.8M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
J&J USD 7.3B 189M 2025-03
Malin Corporation EUR 15.4M 0 2020-12
Merck USD 2.76B 944M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Otsuka Holdings JPY 156.65B 21.04B 2025-03
Pfizer USD 2.59B 3.06B 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



ALKERMES 売上原価 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - May 2025.